An interventional study of ACT_based intervention and Active Control group in Anxiety, Somatization and Depressive Symptom, sponsored by University of Guadalajara. Completed at 1 site in Mexico. Open to participants aged 18 Years to 26 Years. Per ClinicalTrials.gov, last updated 2026-09-10.
Sponsored by University of Guadalajara · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 65 studies in Depression with a site in Mexico — 10 open to participants now, 11 under way, 2 of them phase 3. Depression · Mexico.
Among the 65 studies in Depression with a site in Mexico, this one is the 28th largest by enrollment of the 51 interventional ones that give a count, is one of 8 that started in 2024, is one of 24 with no phase, and was the 65th registered.
8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.
Browse Depression studies →10 of the 65 studies in Depression with a site in Mexico are open now. Recruiting first, the newest first:
Eli Lilly and Company · Sites in Mexico, United States, Australia and 12 more countries
Ages 18–75
Eli Lilly and Company · Sites in Mexico, United States, Australia and 12 more countries
Ages 18–75
Instituto Nacional de Rehabilitacion · Sites in Mexico
Ages 18–65 · Healthy volunteers
Universidad de Guanajuato · Sites in Mexico
Ages 18–60
Aditi Bunker · Sites in Mexico, Burkina Faso, Fiji and 2 more countries
Ages 18+ · Healthy volunteers
A study can be open while its sites in Mexico have not opened yet or have stopped. Only those recruiting at a site in Mexico →
Of the 1,089 Depression studies recruiting now, 470 (43%) set no upper age limit and 519 (48%) stop at 75 or younger; 203 take children under 18; 311 take healthy volunteers.
This study: 18 Years to 26 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
65 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 1 · Phase 2 6 · Phase 3 20 · Phase 4 1
First in 2004; this study’s year is marked. 8 started in 2024.
By drug class, each counting the studies that test any of its medicines:
This study's enrollment of 135 is above the median of 81 across 7,066 interventional studies indexed under Depression.
Median enrollment 159 across the 51 interventional studies, 753 across the 14 observational. Of the 39 that completed or were terminated, 11 (28%) have results posted.
This tab as a report to print or save as PDF → With an account.
25 of 65 have an industry lead sponsor. The 10 most frequent:
University of Guadalajara is the lead sponsor of 95 studies on the registry; 18 are open to participants now.
University of Guadalajara has 3 studies filed under Depression — fewer than ten, so there is no comparison to draw.
3 of the studies in Depression with a site in Mexico that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07578142AccexibleAcceXible Speech-Based Screening for Depression and Anxiety in University Students (UAQ, Mexico) | 2027-09 |
| NCT06834893Aditi BunkerAssessing the Effects of Cool Roofs on Indoor Environments and Health in Colima, Mexico | 2027-09-01 |
| NCT06579950Aditi BunkerAssessing the Effects of Cool Roofs on Indoor Environments and Health | 2027-09-30 |
Add all 3 to your calendar (.ics) → With an account.
Among the 65 studies in Depression with a site in Mexico, from their registry updates:
This tab as a report to print or save as PDF → With an account.
Objective: To evaluate the association between ACT-process with negative psychological variables in a cross-sectional design, and to evaluate the effect of an ACT-based intervention to diminish anxiety in a sample of medical students.
Methods: An ACT-based intervention was designed to diminish anxiety in medical students and implemented in 4 in-person sessions, the pre-test and post-test measurements were performed one week before and one week after the first and last sessions respectively. The control group received a mental health psychoeducational intervention of 90 minutes. The students were intentionally assigned to each study group based on schedule availability. The cross-sectional study was performed with the pre-test measurements in the students of both groups.\<
Here we detail the methodology employed:
PARTICIPANTS AND METHODS Ethics The study was performed according to the Declaration of Helsinki. The protocol was approved by the Research and Ethics Committees of CUCS of the University of Guadalajara with the approval number CI-03023. All participants signed an informed consent form prior to enrollment. The interventions were delivered by health professionals trained in ACT.
Participants Adult medical students at the Health Sciences University Center of the University of Guadalajara who were studying from first to third semesters were invited to participate. The exclusion criteria were a) students that were participating in other psychological of intervention program, and b) students that did not complete all the sessions of the intervention.
Study period: The study was performed in two time points, one in 2023 and the second in 2025, in these two time points the intervention was performed to different participants by different instructors, finally the analyses were conducted with the combined sample.
Measurements Variables: The following variables were measured: psychological flexibility, assessed through four instruments corresponding to ACT-specific processes: the Acceptance and Action Questionnaire-II (AAQ-II) (Espinosa et al., 2010), range 1 - 7, measuring experiential avoidance; the Cognitive Fusion Questionnaire (CFQ) (Ruiz et al., 2017), range 1 - 7, measuring cognitive fusion; the Mindful Attention Awareness Scale (MAAS) (López-Maya, 2015), range 1 - 6, measuring mindfulness, and the Valuing Questionnaire (VQ), (Ruiz et al., 2021), range 0 - 6, measuring consistency with personal values. Negative psychological variables included anxiety, measured with the Generalized Anxiety Disorder scale (GAD-7), range 0 - 3, (Spitzer \& Kroenke, 2006; García-Campallo et al., 2010), depression, measured with the Patient Health Questionnaire-9 (PHQ-9), (Kroenke et al., 2001; Baader et al., 2012), range 0 - 3, somatization, measured with the Patient Health Questionnaire-15 (PHQ-15) (Ros-Montalbán et al., 2010), range 0 - 2, and stress, measured with the Perceived Stress Scale (PSS-14) (Cohen et al., 2010; Remor et al., 2006), range 0 - 4. Sleep satisfaction was assessed with the first item of the Oviedo Sleep Questionnaire (Bobes-García et al., 2000), range 1 to 7.
Sociodemographic and personal variables including age, sex, semester, relationship status (yes, no), socioeconomic level, measured as low, medium and high, alcohol and smoking consumption frequency (from never to 4 or more times in the week), daily minutes of physical activity, daily hours of free time, employment status (yes, no), history of psychological treatment (yes, no), and the number of self-reported health condition (21 different conditions including anxiety, depression, skin diseases, overweight, migraine, colitis, gastritis, allergies, gastrointestinal or respiratory infections, sinusitis, thyroid problems, hypertension, anorexia/bulimia, high cholesterol, renal problems, diabetes, rheumatic conditions, cardiac diseases, cerebral stroke and cancer). The presence of suicide ideation and suicide behavior were measured with the questions: "have you had thoughts of taking your own life?" and "have you taken any actions to try to take your own life?", respectively (answer options, yes, no). All these variables were collected via a Google Forms questionnaire.
Study 1. Design: Study one consisted in a cross-sectional design aimed in determining the correlation among the ACT-related variables with anxiety, depression and stress.
Participants: The participants were those who complied the selection criteria previously described.
Variables: The variables previously described and measured in the pre-test of the intervention program were included for this analysis.
Study 2. Design: This is a cuasi-experimental design with a pre-test and post-test measurements and a control group (psychoeducational session).
Participants: The students were directly invited in their classrooms to either of the 2 interventions in order to facilitate their participation in one schedule, those who accepted to participate were summoned at the University facilities in a schedule convenient for them and the instructor, to receive either the intervention program or the psychoeducational session on mental health.
Procedures: The experimental group received four weekly in-person group sessions based on ACT, conducted at the university facilities. The sessions addressed the six core processes of ACT (acceptance, cognitive defusion, being present, self as context, values, and committed action), with the therapeutic content oriented toward anxiety management. Session duration was 90 to 120 minutes. The sessions program is described in Table 1. The control group received a single psychoeducational session on mental health (90 minutes duration), which included a brief explanation of some techniques for anxiety regulation.
Variables: The previously mentioned variables were measured one week before intervention and 1 week after the final session. Measurements in the control group were conducted at the same time points as those in the intervention group. All measurements were performed via a google form questionnaire.
Table 1. Session program implemented in the intervention group Session number Objective General procedure
ACT: Acceptance and commitment therapy. Statistical analysis Descriptive statistics were obtained with means and standard deviations for quantitative variables with parametric distributions and with median and interquartile range for quantitative variables with non-parametric distributions. For qualitative variables frequencies and percentages were obtained. To perform the description of negative psychological variables including anxiety, depression, stress and somatization we obtained 4 to 5 categories (from low to severe) by dividing the possible range of each variable in the number of categories, the categories were determined according to the original instrument recommendations. To evaluate the instrument reliability of all psychological variables, the Cronbach alpha test was performed.
Study 1: Associations between ACT-specific variables, sociodemographic variables, and negative psychological variables were analyzed using Pearson's and Spearman's correlation tests depending on the data distribution. To determine the variables most associated with anxiety we performed a multivariate regression analysis using the stepwise method and including all the studied variables (dichotomous, quantitative and ordinals) as independent variable and excluding suicide ideation, suicide behavior and the negative psychological variables (depression, stress and somatization), this last by considering that these variables would not add information as effective predictors and possible objectives to reduce anxiety.
Study 2: To compare quantitative variables between groups at baseline, the student's t-test or Mann-Whitney U test was applied for parametric and non-parametric distributions, respectively, and the chi-squared test or Fisher's exact test was used for qualitative variables. To evaluate the effect of the intervention, the difference in each variable (posttest minus pretest) was compared between the experimental and control groups using the student's t-test or Mann-Whitney U test. Effect sizes were calculated using Cohen's D test. All analyses were conducted with SPSS software 31 and JASP program (JASP version 0.95.2) (JASP, 2025).
8,582 studies on the registry are indexed under Depression; 1,723 are open to participants now.
This study's enrollment of 135 is above the median of 81 across 7,066 interventional studies indexed under Depression.
Browse Depression studies →University of Guadalajara is the lead sponsor of 95 studies on the registry; 18 are open to participants now.
Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
This arm was assigned to the ACT\_based therapy, which consisted in 4 weekly sessions of 2 hours, including information about: : Session number Objective General procedure 1.- Acceptance To facilitate the development of acceptance regarding unpleasant internal experiences (thoughts, emotions and physical sensations related with anxiety) 2.- Defusion and contact with the present moment. To reduce the impact of thoughts in anxiety or psychological distress by developing skills for cognitive defusion, by observing thoughts without becoming entangled in them, and conscious contact with the present moment. 3.- Me as a context and living values To foster a flexible perspective of the self (self as a context) and clarify personal values as compass for behavior, regardless of the presence of difficult internal experiences 4.- Committed action: promote execution of behaviors aligned with personal values
Behavioral: ACT_based intervention
This group was assigned to an active computation group which consisted in a single psychoeducational 90 minutes session about mental health, which included the explanation of techniques to diminish anxiety
Behavioral: Active Control group
Session number Objective General procedure 1. \- Acceptance To facilitate the development of acceptance regarding unpleasant internal experiences (thoughts, emotions and physical sensations related with anxiety) 2. \- Defusion and contact with the present moment. To reduce the impact of thoughts in anxiety or psychological distress by developing skills for cognitive defusion, by observing thoughts without becoming entangled in them, and conscious contact with the present moment. 3. \- Me as a context and living values To foster a flexible perspective of the self (self as a context) and clarify personal values as compass for behavior, regardless of the presence of difficult internal experiences 4. \- Committed action: promote execution of behaviors aligned with personal values
This group received a 90-minutes psychoeducational session about mental health including a brief explanation of what anxiety is, its risk factors and symptoms and techniques for anxiety regulation including the psychological interventions as Behavioral therapy, acceptance and commitment therapy and mindfulness, and the description of conductual changes that can reduce anxiety.
Anxiety symptos
This measure was performed with the General Anxiety Disease (GAD-7) questionnaire.
Time frame: From enrollment to the end of the study after 4 weeks
Plan to share: No — We do not plan to share IPD, as the according to the local ethics committee, we are not allowed to share this information being considered confidential
No publications or documents are linked to this record.
Ran from Aug 2024 to primary completion in Dec 2025, 16 months.
Of 3,471 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 16 months is below that.
Counting every sponsor, half of 3,569 studies reached it within 21 months; a quarter within 9 and three quarters within 41.
How these figures are worked out, and which studies are left out of them.
This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Guadalajara